Targeted delivery and stimulus-responsive release of anticancer drugs for efficient chemotherapy

Chemotherapy is currently an irreplaceable strategy for cancer treatment. Doxorubicin hydrochloride (DOX) is a clinical first-line drug for cancer chemotherapy. While its efficacy for cancer treatment is greatly compromised due to invalid enrichment or serious side effects. To increase the content o...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiao, Lei, Yuan, Xue, Peng, Hui, Shan, Guisong, Gao, Min, Yi, Xiaoqing, He, Xiaoyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530493/
https://www.ncbi.nlm.nih.gov/pubmed/34668829
http://dx.doi.org/10.1080/10717544.2021.1986602

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530493/
https://www.ncbi.nlm.nih.gov/pubmed/34668829
http://dx.doi.org/10.1080/10717544.2021.1986602

Ejemplares similares